Inmed Pharmaceuticals Inc (INM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Inmed Pharmaceuticals Inc

Healthcare (1110)

(604) 669-7207

1445-885 WEST GEORGIA ST., VANCOUVER

Nächster Verdiensttermin

Neueste SEC-Einreichungen

INM's Discussions on Twitter

Compare INM vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INM Inmed Pharmaceuticals Inc	1.72	5.70M	3.25M	-8.34M	-7.71M	-2.5755
TAK Takeda Pharmaceutical Co Adr	15.87	51.34B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.26	41.15B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.74	39.67B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	80.81	34.09B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	578.01	24.13B	3.17B	1.29B	1.01B	27.09

Inmed Pharmaceuticals Inc Aktie (INM) Neueste Nachrichten

Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Compare INM vs TAK, HLN, TEVA, ZTS, UTHR

Inmed Pharmaceuticals Inc Aktie (INM) Neueste Nachrichten

InMed-Mentari migraine merger backed by $290 million financing reshapes company strategy (INM) - MSN

InMed Pharmaceuticals Q3 2025 Earnings: Continued Losses as Stock DeclinesTrough Earnings Signal - Newser

InMed Pharmaceuticals Q3 2025 Earnings: Net Loss Widens Amid Pipeline FocusFree Market Insights - Newser

InMed Pharmaceuticals Shares Surge Following Mentari Merger Announcement - HarianBasis.co

ADAR1-managed funds add 468,551 InMed (INM) shares in open-market buys - Stock Titan

InMed (INM) major holder ADAR1 reports 331,449 indirect shares on Form 3 - Stock Titan

InMed Pharmaceuticals Merges with Mentari Therapeutics to Target Migraine Prevention - HarianBasis.co

INM Stock Alert: What to Know as InMed, Mentari Announce Merger - Barchart.com

/C O R R E C T I O N -- InMed Pharmaceuticals/ - PR Newswire

Mentari Therapeutics: $290 Million Private Placement Supports Merger With InMed Pharmaceuticals To Advance Migraine Prevention Therapies - Pulse 2.0

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested - TechStock²

Penny stock InMed Pharmaceuticals merger deal targets migraine pipeline - MSN

Mentari lists via InMed merger, takes $290m for migraine pipeline - The Pharma Letter

InMed Pharmaceuticals (INM) Soars 170% on Merger with Mentari Th - GuruFocus

Law firm investigates InMed Pharmaceuticals' board over possible unfair sale to Mentari Therapeutics - Pluang

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM) - GlobeNewswire

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM) - GlobeNewswire Inc.

Mentari, InMed Merge In Deal Backed By $290M Funding - Law360

InMed Pharmaceuticals, Inc. (INM) Stock: Climbs on $290M Private Placement and Migraine Pipeline Deal - parameter.io

InMed Pharmaceuticals and Mentari Therapeutics Announce $290M Merger to Advance Migraine Prevention Therapies - Minichart

InMed Pharmaceuticals Lowers Armistice Preferred Investment Option Exercise Price from $16.60 to $0.80 - Minichart

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

InMed amends warrant terms, cuts exercise price to $0.80 - Investing.com UK

InMed Soars 100% on $290M Migraine Deal - TechStock²

InMed Pharmaceuticals (INM) Merges with Mentari Therapeutics for Migraine Treatment Development - GuruFocus

Trending Stocks Today | Amesite Surges 150.6% - Moomoo

InMed amends warrant terms, cuts exercise price to $0.80 By Investing.com - Investing.com South Africa

A migraine drugmaker heads to the public markets through reverse merger - BioPharma Dive

INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders - The Joplin Globe

User - The Chronicle-Journal

InMed-Mentari Migraine Merger Backed by $290 Million Financing Reshapes Company Strategy (INM) - Yahoo Finance

InMed (INM) agrees merger with Mentari; Mentari investors to hold ~98.5% - Stock Titan

Mentari Therapeutics to go public via InMed (NASDAQ: INM) merger - Stock Titan

InMed Pharmaceuticals stock surges on Mentari merger deal By Investing.com - Investing.com Nigeria

Penny Stock InMed Pharmaceuticals Merger Deal Targets Migraine Pipeline - Benzinga

INM Stock Jumps On Heavy Volume As Traders Scan Charts - StocksToTrade

InMed Pharmaceuticals stock surges on Mentari merger deal - Investing.com UK

InMed Pharmaceuticals Announces Merger with Mentari Therapeutics - Intellectia AI

INM Stock Slides As Traders Weigh Cash Runway And Steep Losses - timothysykes.com

Hehehe! Cut off the ticker symbol! And Diluted cost! Hehehe! - Moomoo

InMed and Mentari announce all-stock merger deal (INM:NASDAQ) - Seeking Alpha

InMed Pharmaceuticals InMed shareholders are expected to own approximately 1.51% of combined company - marketscreener.com

Inmed Pharmaceuticals Inmed Shareholders Are Expected To Own Approximately 1.51% Of Combined Company - TradingView

According to the latest disclosure, following the completion of the relevant transaction, the pro forma equity value of the merged company, InMed Pharmaceuticals Inc, is expected to reach approximately $421.4 million. - Bitget

Press Release: InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies - Moomoo

InMed Pharmaceuticals Lowers Exercise Price on Preferred Options - TipRanks

InMed (INM) slashes Armistice option exercise price from $16.60 to $0.80 - Stock Titan

Armistice can buy 278,761 InMed shares at $0.80 after deal - Stock Titan

InMed Highlights INM-901 Alzheimer’s Data in Q3 Update - TipRanks

TradingKey - TradingKey

Pharmaniaga Bhd. (PHARMA) - Minichart

Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie INM